Ligand ID: POD


Drugbank ID:
DB01179
(Podofilox)



Indication:
For treatment of external genital warts (Condyloma acuminatum).


Get human targets for POD in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'POD' AND SARS-RELATED PROTEINS ONLY

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
View Interface RMSD Seq.
Identity (%)
HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
1qz8 POLYPROTEIN 1AB
(SARSr-CoV)
5 / 12
CYH B  14
ALA B  28
LEU B  45
ALA B  43
VAL B  41
1.37A13.78
18.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
1uk2 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 268
ALA A 267
LEU A 271
MET A 276
ALA A 211
1.52A22.17
20.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
1uw7 NSP9
(SARS-COV
HKU-39849)
5 / 12
CYH A  14
ALA A  28
LEU A  45
ALA A  43
VAL A  41
1.48A15.30
18.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
1wnc E2 GLYCOPROTEIN
(SARSr-CoV)
5 / 12
VAL F1157
LEU A 927
ALA A 926
LYS A 929
LEU A 930
1.25A12.67
16.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU B1268
ALA B1267
LEU B1208
VAL B1261
ALA B1260
1.50A22.17
21.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
1zv8 E2 GLYCOPROTEIN
(SARSr-CoV)
5 / 12
VAL J   9
LEU I  27
ALA I  26
LYS I  29
LEU I  30
1.52A6.21
6.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
2a5k 3C-LIKE PEPTIDASE
(SARSr-CoV)
5 / 12
LEU A 268
ALA A 267
LEU A 271
MET A 276
ALA A 211
1.52A21.93
20.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)
5 / 12
LEU D 194
ALA D 199
LEU D 192
VAL D 337
ALA D 336
1.36A17.46
17.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
2beq SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
VAL F1158
LEU C 927
ALA C 926
LYS C 929
LEU C 930
1.50A8.46
6.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)
5 / 12
LEU C  13
ALA C  18
LEU C  11
VAL C 156
ALA C 155
1.37A16.81
17.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
5 / 12
VAL C 221
LEU C 254
ASN C 216
ALA C 247
ALA C 250
1.43A21.79
21.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
2ghv SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
VAL E 354
CYH C 378
LEU C 377
LEU C 374
ALA E 350
1.33A20.00
16.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
2op9 REPLICASE
POLYPROTEIN 1AB
(PP1AB, ORF1AB)
3C-LIKE PROTEINASE
(3CL-PRO, 3CLP)
(SARSr-CoV)
5 / 12
LEU A 268
ALA A 267
LEU A 271
MET A 276
ALA A 211
1.51A22.03
20.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
2w2g NSP3
(SARSr-CoV)
5 / 12
VAL B 611
LEU B 648
ALA B 621
VAL B 641
ALA B 640
1.54A19.31
18.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
3avz 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 268
ALA A 267
LEU A 208
VAL A 261
ALA A 260
1.52A21.95
21.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
3bgf SPIKE PROTEIN S1
(SARSr-CoV)
5 / 12
VAL S 389
LEU S 355
LEU S 421
VAL S 328
ALA S 331
1.50A19.85
16.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
3ee7 REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)
5 / 12
CYH C  14
ALA C  28
LEU C  45
ALA C  43
VAL C  41
1.45A11.97
13.15
None
None
GOL  C 123 ( 4.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
3fzd 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 268
ALA A 267
LEU A 271
MET A 276
ALA A 211
1.55A22.49
20.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU B 268
ALA B 267
LEU B 208
VAL B 261
ALA B 260
1.55A23.11
20.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
3sci SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
VAL E 389
LEU E 355
LEU E 421
VAL E 328
ALA E 331
1.52A19.65
16.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
4m0w REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)
5 / 12
VAL A 221
LEU A 254
ASN A 216
ALA A 247
ALA A 250
1.42A21.13
21.54
None
GOL  A 406 (-4.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
4ovz PAPAIN-LIKE
PROTEINASE
(SARS-COV
Urbani)
5 / 12
VAL A 221
LEU A 254
ASN A 216
ALA A 247
ALA A 250
1.35A21.96
21.84
None
None
None
P85  B 902 ( 4.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
5b6o 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU B 268
ALA B 267
LEU B 271
MET B 276
ALA B 211
1.54A21.91
21.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
5c8u GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)
5 / 12
VAL A 108
CYH B  39
LEU B  38
VAL B  29
ALA B  23
1.49A16.70
14.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
5tl7 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
5 / 12
VAL D 221
LEU D 254
ASN D 216
ALA D 247
ALA D 250
1.33A21.96
21.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
5x29 ENVELOPE SMALL
MEMBRANE PROTEIN
(SARSr-CoV)
5 / 12
VAL B  14
LEU A  21
LEU A  18
ASN A  15
ALA B  22
1.41A11.31
11.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
5x58 SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)
5 / 12
VAL C 172
ALA C 233
LEU C 235
ALA C 250
ALA C  91
1.55A16.32
16.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
5x5f S PROTEIN
(MERS-CoV)
5 / 12
ALA A1130
LEU A 894
VAL A1026
LYS A1021
ALA A1025
1.53A14.95
16.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
5y3e REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)
5 / 12
VAL A 221
LEU A 254
ASN A 216
ALA A 247
ALA A 250
1.47A21.85
21.79
None
GOL  A 407 (-4.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
VAL C1076
LEU B 898
MET B 882
VAL C1111
ALA C1069
1.47A16.68
16.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
6acj ACE2
(Homo
sapiens)
5 / 12
LEU D 560
ALA D 396
ASN D 394
VAL D 404
ALA D 403
1.53A20.85
21.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
5 / 12
VAL B 389
LEU B 355
LEU B 421
VAL B 328
ALA B 331
1.38A16.81
17.64
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
6jyt HELICASE
(SARSr-CoV)
5 / 12
ALA A 321
LYS A 323
LEU A 325
ALA A 296
ALA A 292
1.36A20.23
21.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
6m1d ACE2
(Homo
sapiens)
5 / 12
ALA D 550
LEU D 554
ASN D 556
MET D 557
ALA D 528
1.31A19.61
20.58
None